Im Arzneiverordnungs-Report 2006 (1) sind 21 Arzneimittel mit neuen Wirkstoffen aufgef\u00fchrt (Tab. 1), von denen allerdings nur 11 wirklich innovativ sind, d.h. ein neuartiges Wirkprinzip mit klinischer Relevanz haben (Bewertung A nach Fricke). Wenn man diejenigen Arzneimittel noch hinzuz\u00e4hlt, die zwar nicht innovativ, aber verbessert sind bez\u00fcglich Pharmakodynamik und\/oder Pharmakokinetik (Bewertung B nach Fricke), so […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Im Arzneiverordnungs-Report 2006 (1) sind 21 Arzneimittel mit neuen Wirkstoffen aufgef\u00fchrt (Tab. 1), von denen allerdings nur 11 wirklich innovativ sind, d.h. ein neuartiges Wirkprinzip mit klinischer Relevanz haben (Bewertung A nach Fricke). Wenn man diejenigen Arzneimittel noch hinzuz\u00e4hlt, die zwar nicht innovativ, aber verbessert sind bez\u00fcglich Pharmakodynamik und\/oder Pharmakokinetik (Bewertung B nach Fricke), so […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[330,750,122,3073,4317,1809,1436,776,1071,123,2454,255,523,524,4315,470,467,749,748,4318,1354,2156,1377,1353,711,526,271,4319,4314,1374,699,1816,702,2155,4316,1391,98,99,100,125,751,1380,4323,3615,430,1145,4326,4322,1438,257,1383,3792,3324,4324,4325,4320,3791,2161,4321,1439,3323,3186,1143,1074,1399,4313,803,802,1352,1347,520,521,747,232,262,264],"class_list":["post-2137","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-5-hydroxytryptamin-rezeptor-antagonisten","tag-adhs","tag-aids","tag-akromegalie","tag-alitretinoin","tag-anagrelid","tag-anti-parkinson-mittel","tag-anticholinergika","tag-antiemetika","tag-antiretrovirale-therapie","tag-argatroban","tag-arzneimittel","tag-arzneimittelverordnungen","tag-arzneiverordnungen","tag-arzneiverordnungs-report-2006","tag-asthma","tag-asthma-bronchiale","tag-attention-deficit-hyperactivity-disorder","tag-aufmerksamkeitsdefizit-hyperaktivitaetssyndrom","tag-augenentzuendungen","tag-belastungsinkontinenz","tag-bevacizumab","tag-blasenschwaeche","tag-blasenueberaktivitaet","tag-bronchialkarzinom","tag-buchbesprechung","tag-chemotherapie","tag-ciclesonid","tag-darifenacin","tag-dranginkontinenz","tag-emesis","tag-epileptische-anfaelle","tag-erbrechen","tag-erlotinib","tag-gadoxetsaeure","tag-harnblase","tag-heparin","tag-heparininduzierte-thrombozytopenie","tag-hit","tag-hiv-infektion","tag-hyperkinetisches-syndrom","tag-hyperparathyreoidismus","tag-kaposi-sarkom","tag-kataplexie","tag-kolonkarzinom","tag-kolorektales-karzinom","tag-lanreotid","tag-loteprednol","tag-m-parkinson","tag-medikamente","tag-mrt-kontrastmittel","tag-mukositis","tag-mykosen","tag-natriumoxybat","tag-nitisinon","tag-omalizumab","tag-palifermin","tag-palonosetron","tag-paricalcitol","tag-parkinson-syndrom","tag-posaconazol","tag-rasagilin","tag-rektumkarzinom","tag-thrombozythaemie","tag-tipranavir","tag-tyrosinaemie-typ-1","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren","tag-ueberaktive-blase","tag-urininkontinenz","tag-verordnungsverhalten","tag-verschreibungsverhalten","tag-zappelphilipp-syndrom","tag-zonisamid","tag-zytostatika","tag-zytostatische-therapie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2137"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2137\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}